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Objective. The use of cumulative live birth rate (CLBR) per ovarian stimulation cycle is proving to be an accurate method to
calculate the success of IVF; however, the cycle outcome is closely associated with the number of embryos transferred (ET).
Our aim was to report CLBR after IVF according to the number of embryos required to achieve a live birth in women aged ≥35
years, considering age, body mass index (BMI), and ethnicity. Methods. We conducted a retrospective cohort study including 1344
patients who underwent IVF between January 2013 and June 2016 at the First Affiliated Hospital of Xinjiang Medical University.
The cumulative probability of live birth for each couple was estimated using the Kaplan–Meier method, and survival curves were
compared according to age, BMI, and ethnicity using the log-rank test. Results. CLBR increased rapidly from 1 to 5 ETs, moderately
from 6 to 10 ETs, and slowly thereafter. CLBR was significantly different across 4 categories based on BMI as well as across those
based on age; low CLBR was significantly associated with the age of ≥42 years and obesity. Conclusion. The association between
CLBR and number of ET provides realistic and precise information regarding the success of IVF and can be applied to guide
clinicians and patients.
1. Introduction
The emergence of assisted reproductive technology (ART)
has brought hope to infertile couples. Since the birth of the
world’s first “test tube baby,” Louise Brown, 40 years ago,
8 million babies have been conceived worldwide through
ART [1]. However, IVF success rate remains far below
100%. Therefore, the ratio of probability of success and cost
effectiveness is an important indicator of decision making
and should be considered as a key point for patients who have
a low ratio [2].
Typically, cumulative live birth rate (CLBR) and preg-
nancy rate are used as key indicators to assess the qual-
ity and success of IVF, and these are indispensable for
patients to make decisions before starting the treatment [3,
4]. CLBR allows for relevant comparison between different
reproductive medical centers. Moreover, it may help patients
make decisions regarding continuing treatment or remaining
childless.
There is a growing tendency in some countries for couples
to have children late in their life. This situation is obvious
in China for several reasons, such as the two-child policy
issued in 2015 [5]. In addition, Chinese women tend to receive
education for a prolonged period during their lifespan, which
means that they may get married late and consequently
postpone childbearing; women with higher education may
focus more attention on their career.Apart from these reasons
involving women, the high cost of living (burden of feeding a
family and offering high-quality education for children) may
contribute to late marriages.
According to a recent study, nearly 57% of the couples
of all ages in United Kingdom remained childless even after
undergoing 6 complete IVF cycles [6]. Female age is the main
factor related to delivering a child through ART [7]. That is,
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women aged ≥35 years would show a lower live birth rate
in a single cycle than younger women. Thus, patients older
than 35 years of age require multiple cycles to increase the
probability of live birth. However, many patients discontinue
treatment after 1 or 2 failed treatment cycles at the beginning
of ART, although the final prognosis of achieving a live birth
may remain promising. Furthermore, the number of embryos
transferred (ET) in each cycle varies from 1 to 3, with 3 being
the maximum. This reinforces that CLBR per cycle may not
be a reliable index for providing informed advice to patients.
The aim of this study was to calculate CLBR per total
number of ET required for achieving a live birth. This prag-
matic method predicted outcomes considering each embryo
as single opportunity to achieve a live birth. This approach is
advantageous in that it can provide doctors and patients with
a more accurate probability of live birth. Female age, BMI,
and ethnicity were considered the key factors affecting the
success of IVF.
2. Methods
2.1. Study Design and Samples. We performed a retrospective
cohort study including 1344 women aged 35–45 years who
underwent IVF/ET between January 2013 and June 2016 at the
ReproductiveMedicine Center, the FirstAffiliated Hospital of
Xinjiang Medical University, Xinjiang, China. The inclusion
criteria were as follows: (1) women with a ≥1-year history of
infertility and age of ≥35 years; (2) those undergoing the first
cycle of IVF/ICSI; and (3) those in whom own oocytes were
used and fresh or frozen-thawed embryos were transferred
without preimplantation genetic screening for embryo ane-
uploidies. The exclusion criteria were as follows: (1) patients
undergoing IVF cycles without ET for any reason; (2) those
unsuitable for treatment because of severe disease; (3) those
with unknown clinical outcome; (4) those aged>45 years; and
(5) those with congenital uterine dysplasia. This study was
approved by the Institutional Review Board (IRB) of the First
Affiliated Hospital of Xinjiang Medical University, and all
patients provided written informed consent before treatment.
2.2. Follow-Up. All patients were followed up for at least
2 years or until (1) they decided to discontinue the IVF
treatment; (2) all embryos were transferred; (3) they decided
to change to ovum donation; (4) had delivery of at least 1 live
child surviving over 1 month; or (5) they were still receiving
IVF treatment at the end of the study.
2.3. Data Collection. Data were obtained from the ART
records of the Reproductive Medicine Center without any
patient identifier information. The following information
was collected: maternal age (≤37 years, 38–39 years, 40–41
years, and ≥42 years); ethnicity (Han, Vygur, and others);
basal serum FSH level; basal luteinizing hormone level;
infertility duration; body mass index (BMI; underweight:
<18.5 kg/m2, moderate: <18.5–24.9 kg/m2, overweight:
25.0–29.9 kg/m2, and obese: >30 kg/m2); retrieved oocyte
number; gonadotropin (Gn) dosage, Gn day, total number of
ET (number of ET to achieve a live birth (ETRL); 1–3 ETRL,
4–6 ETRL, 7–9 ETRL, and >10 ETRL); number of metaphase
II oocytes obtained; and outcomes in terms of pregnancy
(include ongoing pregnancy), miscarriage, and live birth.
The primary outcome was live birth, defined as any birth
event in which at least 1 baby was born alive and survived for
more than 1 month.
2.4. Statistical Analysis. To summarize the characteristics
of patients, continuous variables were expressed as mean
(standard deviation, SD) or median (interquartile range,
IQR) and categorical variables were expressed as frequency
(percentage). Categorical variables were compared using the
𝜒
2 or Fisher’s exact test. Continuous variables were compared
using t test, analysis of variance, or Mann–Whitney U test,
depending on data distribution.
The cumulative probability of live birth for each couple
undergoing IVF/ICSI treatment during the study period
was calculated using the Kaplan–Meier method; this was
according to the total ET in each cycle of treatments required
to achieve a live birth. The probability of cumulative live birth
and outcomes were estimated by the Kaplan–Meier method
and compared using the log-rank, Breslow, and Tarone–Ware
tests according to each categorical group. A two-tailed P<
0.05 was considered statistically significant in all analyses. All
analyses were performed using Stata 13 and R version 3.3.1
(http://www.r-project.org/).
3. Results
3.1. Baseline Characteristics. The cohort included 1344
patients aged 35–45 years who underwent IVF/ICSI cycles
involving 2596 ET. Demographical and clinical characteristic
of patients are summarized in Tables 1 and 2. Mean and
median number of embryos transferred was 1.7(SD: 0.48)
and 2 (IQR: 1.5-2); mean and median number of embryos
transfers was 3.5(SD: 2.28) and 3 (IQR: 2-3). Patients were
assigned to 4 groups according to the number of ET: 1–3
ETRL group with 810 patients (60.3%); 4–6 ETRL group
with 392 patients (29.2%); 7–9 ETRL group with 111 (8.2%);
and >10 ETRL group with 31 patients (2.3%); only 1 patient
required 15 ETRL (Supplementary Table 1). During the
study period, a total of 549 pregnancies were confirmed, of
which 92 pregnancies ended in a miscarriage; therefore, 457
patients achieved a live birth with a CLBR of 34.0% (included
403 singletons and 54 twins). The >10ETRL group showed
the highest miscarriage rate and the lowest CLBR. CLBR of
the 4 ETRL groups was 34.94%, 32.12%, 37.82%, and 19.35%,
respectively.
3.2. Overall and Stratified CLBRs. Figure 1 presents the over-
all CLBR of all participants.After 5 ETRL, the cumulative rate
was 41.1% (95% CI: 37.7%–44.7%), representing an approx-
imate increase at an average of 8% per additional embryo.
When CLBR reached 70.4% (95% CI: 64.3%–76.2%) after
10ETRL and 85% after 15 ETRL, the increase in cumulative
live birth rate was only 3% per embryo.
Figure 2 presents CLBR according to age. Among women
aged <42 years, CLBR was approximately 50% after 6 ETRL.
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Table 1: Clinical characteristics of the treatments according to the number of embryos transferred to reach live birth (ETRL).
From 1–3 ETRL
(n=810)
From 4–6 ETRL
(n=392)
From 7–9 ETRL
(n=111)
More than 10
(n=31)
Overall
P
Female age (years) 37.91±2.41 37.90±2.45 37.65±2.37 37.55±2.19 0.6300
Male age (years) 39.17±4.31 39.03±4.32 38.79±3.82 39.74±3.66 0.6565
BMI (kg/m2) 23.01±3.09 23.00±2.98 23.12±3.18 23.13±3.03 0.9824
Basal FSH 9.14±3.54 8.33±2.91 7.88±2.69 7.70±2.39 <.0001
Basal E2 66.76±102.05 74.42±264.40 77.39±305.45 53.35±36.92 0.8418
Basal LH 4.13±1.75 4.08±1.71 3.82±1.78 4.04±1.75 0.3807
Basal T 0.86±3.81 0.72±3.58 0.57±1.95 0.43±0.38 0.7850
Duration of Infertility
(Months) 66.02±46.90 65.96±46.92 64.52±44.95 70.23±55.54 0.9482
Dysmenorrhea 0.2178
Yes 254( 31.36%) 118( 30.10%) 30( 27.03%) 5( 16.13%) .
No 556( 68.64%) 274( 69.90%) 81( 72.97%) 26( 83.87%) .
Race 0.0034
Han 614( 75.80%) 328( 83.67%) 97( 87.39%) 29( 93.55%) .
Vygur 85( 10.49%) 21( 5.36%) 5( 4.50%) 1( 3.23%) .
Others 111( 13.70%) 43( 10.97%) 9( 8.11%) 1( 3.23%) .
Table 2: Cycle outcomes of the treatments according to the number of embryos transferred to reach live birth (ETRL).
From 1–3 ETRL
(n=810)
From 4–6 ETRL
(n=392)
From 7–9 ETRL
(n=111)
More than 10
(n=31)
Overall
P
GN dose 2887.62±1235.81 2707.54±1139.93 3017.82±748.73 2963.75±625.58 0.9482
(HCGDay)E2 3413.76±3499.26 5412.12±7646.49 4196.45±3757.99 4317.33±3867.31 0.0652
No. of retrieved oocytes 7.72±5.25 11.76±6.42 16.12±7.62 20.83±8.48 0.2450
No. of embryos
transferred 2.02±0.71 4.68±0.79 7.77±0.73 11.35±1.50 0.0466
Pregnancy 335( 41.36%) 154( 39.29%) 50( 45.05%) 10( 32.26%)
Miscarriage /pregnancy
(%) 52( 15.52%) 28( 18.18%) 8( 16.00%) 4( 40.00%)
Live birth 283( 34.94%) 126( 32.14%) 42( 37.84%) 6( 19.35%)
Singleton (%) 248( 30.62%) 110( 28.06%) 39( 35.14%) 6( 19.35%)
Twins (%) 35( 4.32%) 16( 4.08%) 3( 2.70%)
No live birth 527( 65.06%) 266( 67.86%) 69( 62.16%) 25( 80.65%)
Among women aged ≥42 years, there was a dramatic reduc-
tion in CLBR to 25%. CLBR was significantly different among
the 4 age groups (log-rank test: 𝜒2 = 44.38, P < 0.0001).
Figure 3 presents CLBR according to BMI. CLBR signif-
icantly decreased in patients with BMI of >30 kg/m2. After 5
ETRL, CLBR was approximately 50%, 42%, 40%, and 25%,
respectively. Obese women showed CLBR limited to 25%
after 5 ETRL. CLBR was significantly different across BMI
categories (log-rank test: 𝜒2 = 65.29, P < 0.0001).
CLBR was not significantly different across ethnicity
categories (log-rank test: 𝜒2 = 0.53, P = 0.7674; Figure 4).
4. Discussion
We evaluated outcomes of IVF treatment according to the
total number of ET until a term live birth was achieved in
women aged ≥35 years. Although the patients underwent the
same number of treatment cycles, the total number of ET
varied because the number of ET in each cycle varied from 1 to
3. Therefore, considering each embryo as a single opportunity
for achieving a live birth can be a useful method to evaluate
the outcomes of IVF/ICSI treatment, and it has the advantage
of providing more accurate probability of treatment success
to clinicians and patients. The cumulative probability of live
birth was nearly 25% with 3 ET but only half of this rate with
6 ET. This indicates that the number of ET is a determinant
of pregnancy and live birth achievements.
The number of ET was an essential factor associated
with CLBR. This is generally in agreement with other studies
showing that the number oocytes retrieved was a contribut-
ing factor to live birth rate after IVF, with recent evidence
indicating that CLBR increases with the number of oocytes
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Figure 1: Kaplan–Meier curves for CLBR according to the total number of ET required to achieve a live birth in all participants.
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Figure 2: Kaplan–Meier curves for CLBR according to the total number of ET required to achieve a live birth in all age categories.
retrieved [8–11]. Not all oocytes can completely develop into
a mature egg and be successfully fertilized to become an
embryo. Therefore, to obtain 5 embryos, approximately 14
metaphase II oocytes are required, with a fertilization rate
of 70% such that 50% of them could develop to a blastocyst-
stage embryo [12, 13]. Furthermore, patients with polycystic
ovary syndrome (PCOS) typically produce more oocytes,
but they are often of poor quality and show a low rate
of fertilization [14, 15]. Therefore, it seems appropriate and
reasonable to evaluate the IVF outcomes by considering the
number of ET.
Female age is the main factor to achieve a successful
live birth through ART. Natural aging may reduce fertil-
ity in a patient seeking IVF treatment [16]. Women aged
≥35 years present increased risk of abortion, significantly
reduced pregnancy and live birth rates, and increased risk of
pregnancy comorbidities and complications [17–20]. Women
aged ≥46 years were excluded from this study because their
pregnancy rate tended to be 0% under a natural condition
[21], and a recent study suggested that IVF treatment was
futile in women aged ≥44 years (CLBR of 3% was never
reached irrespective of the number of retrieved oocytes) [11].
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Figure 3: Kaplan–Meier curves for CLBR according to the total number of ET required to achieve a live birth in all BMI categories.
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Figure 4: Kaplan–Meier curves for CLBR depending on the total number of ET required to achieve a live birth in all ethnicity categories.
Studies indicated that embryo quality is affected by the age
of the woman [22–24]. Age was found to be a predictor for
the number of retrieved oocytes, number of metaphase II
oocytes and embryo quality [25]. Declines in oocytes yields
and oocytes quality are major reasons for deteriorating IVF
outcomes with advanced female age. Embryo quality was
largely determined by oocytes and embryo quality deter-
mines most of pregnancy and live birth probability.Apossible
explanation for this is that women’s fertility decreases with
increasing age due to a combination of a lowered number of
embryos for transfer and decline in embryo quality associated
with factors including chromosomal aneuploidy, chromoso-
mal errors, fragmentation, and mitochondrial dysfunction
[26–28].
Our results show that IVF overcomes infertility in women
aged ≤41 years. Women at ≥42 years should be informed that
IVF treatment cannot completely overcome reduced fertility
due to age, which is consistent with reports of a previous study
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[11]. The added value of the present findings is that, for women
aged ≥42 years, discontinuation of further treatment may
be recommended after 8 embryos are transferred. Moreover,
women of advanced age should be informed of the increased
risk of pregnancy and perinatal complications. Women who
become pregnant at the age of ≥40 years face increased
risks of stroke and heart attack later in their life compared
with women who become pregnant at a younger age [29].
Increased risk of neonatal birth defects such as Down
syndrome and cerebral palsy is associated with increased age
during pregnancy [18, 30].
Studies assessing the potential impact of female BMI
on IVF outcomes have reported conflicting results. Multiple
studies and a meta-analysis indicated that higher BMI was
associated with fewer retrieved oocytes, higher cancellation
rates, higher miscarriage rate, and lower pregnancy and live
birth rates [31–36]. Meanwhile, other studies reported no
adverse effect of increased BMI on IVF outcomes [37–40].
This difference in conclusions may be due to disparities of
ethnicity, dietary structure, lifestyle, genetics, and environ-
mental factors. Therefore, we categorized BMI into 4 groups
and applied the Kaplan–Meier method to analyze CLBR of
each group. Obese women showed the lowest CLBR among
these 4 groups, and CLBR was limited to 25% after 5 embryos
were transferred. Obese women show dysregulated meiotic
spindle formation, which may lead to reduced size and quality
of oocytes and embryos [41, 42]. Thus, obese women should
be counseled regarding the detrimental effects of obesity and
benefits of weight loss, including improvements in treatment
outcomes, as recommended by a recent meta-analysis.
Our study has several strengths. We considered each
embryo as a single opportunity for achieving live birth. The
plots we produced are easy for clinicians and patients to
understand and show the specific probability of treatment
success according to patient characteristics. We did not
restrict the treatment to 6 cycles as did other studies, [6]
allowing us to assess prognosis to a considerable degree.
Nonetheless, our study has several limitations. First, the
etiology of infertilitywas not considered. There are numerous
reasons for male and female infertility, and some etiologies,
such as mild male factor infertility and low ovarian response,
are difficult to define and classify. Second, we did not consider
embryo quality owing to the lack of standard quantifiable
items to evaluate it. Third, we did not account for confounders
such as smoking status and alcohol intake. Finally, the
retrospective nature of the study cannot exclude all biases.
5. Conclusions
In summary, the present study provides the expected proba-
bility of having a child based on the number of ET. Clinicians
can provide accurate probabilities to patients using visual
graphics such as the Kaplan–Meier curves. This may assist
patients to make difficult decisions regarding whether to
pursue the IVF/ICSI treatment. Women aged ≥42 years may
not experience any benefit with CLBR after 8 embryos are
transferred; thus, they should be discouraged from continu-
ing IVF treatment. Obese women seeking fertility treatment
should be counseled on the detrimental effects of obesity and
benefits of weight reduction, and they should be informed
that weight loss via diet and exercise is associated with
improved probability of becoming pregnant, with a trend
toward improved live birth rate.
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